TransNusa Expands Regional Network With Launch of Jakarta-Penang Route 
PLN Strengthens Its Pathway to the Global Carbon Market Through Energy Transition Investments 
IMPC Commits Rp250 billion (USD 15 million) to Build ASEAN’s Leading Polymer Training Center, Partnering with SKZ-German Plastics Center 
Bitzero Holdings Inc. Announces Commencement of Trading on Canadian Securities Exchange 
OTTICA By Optimax Eyewear Launches New Online Platform for Luxury Eyewear Shopping PROCEPT BioRobotics® Reports Second Quarter 2023 Financial Results and Increases 2023 Revenue Guidance
REDWOOD CITY, Calif., July 27, 2023 (GLOBE NEWSWIRE) — PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the…
Voyager Therapeutics Announces Second Quarter 2023 Conference Call and Webcast
CAMBRIDGE, Mass., July 27, 2023 (GLOBE NEWSWIRE) — Voyager Therapeutics, Inc. (Nasdaq: VYGR) a biotechnology…
Voyager Therapeutics Announces Second Quarter 2023 Conference Call and Webcast
CAMBRIDGE, Mass., July 27, 2023 (GLOBE NEWSWIRE) — Voyager Therapeutics, Inc. (Nasdaq: VYGR) a biotechnology…
Tilray Renews Distribution Agreement With Great North Distributors for Cannabis Sales Across Canada With Newly Expanded Brand Portfolio
Tilray Continues to Lead Cannabis Market Share Across Canada LEAMINGTON, Ontario, July 27, 2023 (GLOBE…
Tilray Renews Distribution Agreement With Great North Distributors for Cannabis Sales Across Canada With Newly Expanded Brand Portfolio
Tilray Continues to Lead Cannabis Market Share Across Canada LEAMINGTON, Ontario, July 27, 2023 (GLOBE…
Chimerix to Report Second Quarter 2023 Financial Results and Provide an Operational Update on August 3, 2023
DURHAM, N.C., July 27, 2023 (GLOBE NEWSWIRE) — Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is…
Chimerix to Report Second Quarter 2023 Financial Results and Provide an Operational Update on August 3, 2023
DURHAM, N.C., July 27, 2023 (GLOBE NEWSWIRE) — Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is…
Optinose Announces Preliminary Second Quarter 2023 XHANCE Net Revenue of $19.5 Million
Second Quarter 2023 Conference Call and Webcast to be held August 10, 2023 at 8:00…
Optinose Announces Preliminary Second Quarter 2023 XHANCE Net Revenue of $19.5 Million
Second Quarter 2023 Conference Call and Webcast to be held August 10, 2023 at 8:00…
Aquestive Therapeutics Announces Positive Topline Pharmacokinetic Data for Anaphylmâ„¢ (epinephrine) Sublingual Film
Anaphylm 12mg Exceeds Lower Bracket at All Expected Pivotal Targets Anaphylm 12mg Exceeds Lower Bracket…
Aquestive Therapeutics Announces Positive Topline Pharmacokinetic Data for Anaphylmâ„¢ (epinephrine) Sublingual Film
Anaphylm 12mg Exceeds Lower Bracket at All Expected Pivotal Targets Anaphylm 12mg Exceeds Lower Bracket…
EyePoint Pharmaceuticals Presents Interim Masked Safety Data and Patient Baseline Characteristics for DAVIO 2 Clinical Trial at OIS Retina Innovation Summit
Interim safety data from the Phase 2 DAVIO 2 trial continues to demonstrate EYP-1901 is…
EyePoint Pharmaceuticals Presents Interim Masked Safety Data and Patient Baseline Characteristics for DAVIO 2 Clinical Trial at OIS Retina Innovation Summit
Interim safety data from the Phase 2 DAVIO 2 trial continues to demonstrate EYP-1901 is…
Plus Therapeutics to Present at the 2023 SNO/ASCO CNS Cancer Conference
AUSTIN, Texas, July 27, 2023 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a…
Plus Therapeutics to Present at the 2023 SNO/ASCO CNS Cancer Conference
AUSTIN, Texas, July 27, 2023 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a…
Kymera Therapeutics to Report Second Quarter 2023 Financial Results on August 3
WATERTOWN, Mass., July 27, 2023 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage…
Kymera Therapeutics to Report Second Quarter 2023 Financial Results on August 3
WATERTOWN, Mass., July 27, 2023 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage…
Fulcrum Therapeutics to Host Second Quarter 2023 Financial Results Conference Call and Webcast on Thursday, August 3, 2023, at 8:00 a.m. ET
CAMBRIDGE, Mass., July 27, 2023 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC),…
Fulcrum Therapeutics to Host Second Quarter 2023 Financial Results Conference Call and Webcast on Thursday, August 3, 2023, at 8:00 a.m. ET
CAMBRIDGE, Mass., July 27, 2023 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC),…
Annexon Biosciences Strengthens Leadership Team with Appointment of Jamie Dananberg, M.D., as Chief Medical Officer
BRISBANE, Calif., July 27, 2023 (GLOBE NEWSWIRE) — Annexon, Inc. (“Annexon”) (Nasdaq: ANNX), a clinical-stage…